Conamep Laboratory

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED2 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• NOT LISTED1 refused line

  Product not listed with FDA

  The product appeared to be a drug or device that is not included in the listing FDA requires under section 510(j) of the FD&C Act.

Questions about Conamep Laboratory

Is Conamep Laboratory on an FDA import alert?

No listing for Conamep Laboratory appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Guatemala page.

Has FDA refused shipments from Conamep Laboratory?

Yes. FDA refused 3 shipment lines from Conamep Laboratory between December 2, 2025 and February 18, 2026. The most recent, on February 18, 2026, was vitamin c (ascorbic acid), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Conamep Laboratory's shipments?

The most frequent charges are UNAPPROVED (unapproved new drug, 2 lines) and NOT LISTED (product not listed with fda, 1 line).

What is Conamep Laboratory's FEI number?

Conamep Laboratory's FDA Establishment Identifier (FEI) is 3027357402.